Okavax
Description
Okavax vaccine contans attenuated Oka strain of Varicella zoster virus. It is indicated for prevention of Chickenpox in persons from 12 months of age.
Immunization Guideline
A single dose of 0.5 mL is injected subcutaneously to persons not less than 12 months of age and with no history of chickenpox.
Additional information
country-of-manufacture | Thailand |
---|---|
manufacturer | Sanofi Pasteur |
package-size | 1 Dose |
pharmaceutical-form | Lyophilized |
preservative | None |
route-of-administration | Subcutaneous |
vaccine-type | chickenpox |
Contraindications | Those suffering from fever, acutely ill, having experienced a previous |